Rana Kesha, Isbel Nicole, Buzza Mark, Dagher Hayat, Henning Paul, Kainer Gad, Savige Judy
University Department of Medicine, Austin and Repatriation Medical Centre, Heidelberg, VIC, Australia.
Am J Kidney Dis. 2003 Jun;41(6):1170-8. doi: 10.1016/s0272-6386(03)00347-0.
Familial forms of focal segmental glomerulosclerosis (FSGS) are caused by mutations in genes at 1q25-31 (gene for steroid-resistant nephrotic syndrome 2 [NPHS2]), 11q21-22, 19q13 (gene for alpha-actinin 4 and NPHS1), and at additional unidentified chromosomal loci.
We describe clinical and histopathologic features and results of linkage analysis in nine consecutive index cases with familial FSGS who, together with their families, were referred for genetic studies.
Two of the index cases presented in childhood (22%) and seven cases presented in adolescence or adulthood (78%). Six of their families (67%), including the two cases with childhood-onset disease, showed probable autosomal recessive inheritance. FSGS segregated at the 1q25-31 locus in two of these families and at the 11q21-22 locus in four families. None had disease caused by mutations in genes at the 19q13 locus, and no locus was identified in the three remaining families. Clinical features of proteinuria, minimal hematuria, hypertension, preeclampsia, and progressive renal impairment were usually present with autosomal recessive or dominant inheritance and with disease that segregated at the different loci. Eighteen renal biopsies from affected members of eight families showed a strong correlation between tubulointerstitial damage and percentage of obsolescent glomeruli (rho = +0.76; P < 0.01). None of the 13 patients from eight families who underwent transplantation developed recurrent FSGS in their grafts. In general, carriers of autosomal recessive disease had no distinctive clinical features apart from the development of preeclampsia in successive pregnancies.
Familial forms of FSGS are not uncommon, and presentation frequently is in adolescence or adulthood, even when inheritance is autosomal recessive. Furthermore, carriers of autosomal recessive FSGS often have no distinctive phenotype.
家族性局灶节段性肾小球硬化(FSGS)由位于1q25 - 31(类固醇抵抗型肾病综合征2 [NPHS2]基因)、11q21 - 22、19q13(α - 辅肌动蛋白4和NPHS1基因)以及其他未确定的染色体位点的基因突变引起。
我们描述了9例连续的家族性FSGS索引病例的临床和组织病理学特征以及连锁分析结果,这些病例及其家族被转诊进行基因研究。
2例索引病例在儿童期发病(22%),7例在青少年期或成年期发病(78%)。其中6个家族(67%),包括2例儿童期发病的病例,显示可能为常染色体隐性遗传。FSGS在其中2个家族中定位于1q25 - 31位点,在4个家族中定位于11q21 - 22位点。没有一个家族的疾病是由19q13位点的基因突变引起的,其余3个家族未确定相关位点。蛋白尿、轻度血尿、高血压、先兆子痫和进行性肾功能损害等临床特征通常在常染色体隐性或显性遗传以及在不同位点分离的疾病中出现。来自8个家族的受影响成员的18次肾活检显示,肾小管间质损伤与废弃肾小球百分比之间存在很强的相关性(rho = +0.76;P < 0.01)。来自8个家族的13例接受移植的患者中,没有一例在移植肾中发生复发性FSGS。一般来说,常染色体隐性疾病携带者除了在连续妊娠中发生先兆子痫外,没有明显的临床特征。
家族性FSGS并不罕见,即使遗传方式为常染色体隐性遗传,发病通常也在青少年期或成年期。此外,常染色体隐性FSGS携带者通常没有明显的表型。